14-16th July 2022, Bern, Switzerland, University Hospital Bern.
All times in CEST
9th I-DSD Symposium Programme
I-DSD 2022 Programme Booklet (including poster list)
Abstracts published in Sexual Development Special Issue
I-DSD Training Workshop – Thursday July 14th 2022 (09:00 -12:30) (Additional registration fee)
Choice of 3 workshops out of 4 lasting 45 mins each
| The I-DSD/I-CAH/I-TS registries Angela Lucas-Herald/Salma Ali Glasgow, UK | Bioinformatic analysis Amit Pandey Bern, Switzerland | Communication with a new parent or patient Katie Traino Oklahoma City, USA | Interpretation of endocrine tests Tülay Güran Istanbul, Turkey |
| Symposium Day 1 (Thursday, July 14th 2022) |
|---|
| Registration & Coffee from 11:30 |
| 13:00: Opening |
| Session 1 – Setting the Scene (13:00-13:35) Chair: Anna Nordenström, Stockholm, Sweden |
| 13:00 – 13:05 Christa Flück, Bern, Switzerland 13:05 – 13:20 Patients’ experiences in Switzerland 13:20 – 13:35 Patient support & advocacy – Arlene Smyth, Turner Syndrome International |
| Session 2 – International Collaboration (13:40-14:15) Chair: Faisal Ahmed, Glasgow, UK |
| 13:40 – 13:45 Endo-ERN – Olaf Hiort, Lübeck Germany 13:45 – 13:50 ESPE DSD working group – Tülay Güran, Istanbul, Turkey 13:50 – 13:55 APEG DSD Working Group – Michele O’Connell, Melbourne, Australia 13:55 – 14:00 PES DSD Working Group – Courtney Finlayson, Chicago, USA 14:00 – 14:05 I-DSD/I-CAH – Christa Flück, Bern, Switzerland 14:05 – 14:15 Discussion |
| Oral Communications 1 (OC1) (14:20-15:30) Chairs: Rade Vukovic, Belgrade, Serbia, Angela Lucas-Herald, Glasgow, UK |
| 14:20 – 14:30 Current management of acute adrenal insufficiency related adverse effects in children with congenital adrenal hyperplasia – results of an international survey of specialist centres – Salma Ali, Glasgow, UK 14:30 – 14:40 Identification of small regions of overlap from copy number variable regions reveals candidate genes and novel chromosome loci for hypospadias – Ina Amarillo, Hershey, USA 14:40 – 14:50 The international SF1 next project: Description of a cohort of 107 individuals with SF-1/NR5A1 variants – Chrysanthi Kouri, Bern, Switzerland 14:50 – 15:00 Pathway to Care among People with Disorders of Sex Development: Cohort Profile – David E Sandberg, Ann Arbor, USA 15:00 – 15:10 Designing a best-worst scaling survey for defining successful outcomes and trade-offs in DSD care – Erica Weidler, Phoenix, USA 15:10 – 15:20 A novel POR variant recurrently found in Argentine patients results in a wide spectrum of undervirilised phenotypes in 46,XY patients – Jimena Lopez Dacal, Buenos Aires, Argentina 15:20 – 15:30 Timing of reconstructive surgery for individuals with differences of sex development (DSD): Stakeholder views on successful outcomes – Kathleen van Leeuwen, Phoenix, USA Coffee Break 15:30 – 16:00 |
| Session 3 – Reaching A Genetic Diagnosis In The Era Of NGS (16:00-17:30) Chair: Olaf Hiort, Luebeck, Germany |
| 16:00 – 16:25 The clinical approach – Ruth McGowan, Glasgow, UK 16:25 – 16:50 Advances in insilico analysis – Katie Ayers, Melbourne, Australia 16:50 – 17:15 Functional analysis – Anu Bashamboo, Paris, France 17:15 – 17:30 Discussion |
| Free Evening |
| Symposium Day 2 (Friday, July 15th 2022) |
|---|
| Session 4 –Adrenal & Gonadal Development (08:15-09:45) Chair: Amit Pandey, Bern, Switzerland |
| 08:15 – 08:40 Mouse models for DSD – Serge Nef, Geneva, Switzerland 08:40 – 09:05 Novel therapeutic models for adrenal disorders – Leo Guasti, London, UK 09:05 – 09:30 Novel models of the gonads – Anna Lauber-Biason, Fribourg, Switzerland 09:30 – 09:45 Discussion |
| Oral communications 2 (OC2) (09:50-11:00) Chairs: Meilan Rutter, Cincinnati, USA, Grit Sommer, Bern, Switzerland |
| 09:50 – 10:00 Caregiver Perceptions of Stigma Associated with their Child’s Difference of Sex Development – Kristina I. Suorsa-Johnson, Salt Lake City, USA 10:00 – 10:10 Sexual Development and prenatal growth. Analysis of the prevalence of being born Small for Gestational Age (SGA) in a large DSD cohort, and the genotypic frequency of GHR gene polymorphism in non-disgenetic undiagnosed 46,XY DSD patients – María Celeste Mattone, Buenos Aires, Argentina 10:10 – 10:20 “I believe God doesn’t make mistakes, and I am wonderfully made in His image”: The intersection of religion/faith and clinical care in Differences of Sex Development – Meilan Rutter, Cincinnati, USA 10:20 – 10:30 Experiences and needs of variation in sex characteristics peer support members in the prenatal setting – Michele O’Connell, Melbourne, Australia 10:30 – 10:40 46,XY Partial gonadal dysgenesis; diagnosis and long-term outcome at puberty – Rieko Tadokoro Cuccaro, Cambridge, UK 10:40 – 10:50 Genital skin wound healing is associated with the extent of external virilisation in boys with hypospadias – Angela Lucas-Herald, Glasgow, UK 10:50 – 11:00 Psychological impact on parents of children born with atypical genitalia in India – Tanvi Bindal, New Dehli, India Coffee Break 11:00 – 11:30 |
| Session 5 – Hypospadias – a disorder of sex development or not (11:30 – 13:00) Chair: Margarett Shnorhavorian, Seattle, USA |
| 11:30 – 11:50 Acquired or genetic – Jorma Toppari, Turku, Finland 11:50 – 12:10 The views of an endocrinologist – Sabine Hannema, Amsterdam, The Netherlands 12:10 – 12:30 The views of a psychologist -Norma Ruppen, Zurich, Switzerland 12:30 – 12:50 The views of a surgeon – Emilie Johnson, Chicago, USA 12:50 – 13:00 Round table Lunch 13:00 – 14:00 |
| Session 6 – Debate (14:00 – 15:15) ‘This house believes that clinical psychology care should be provided proactively in every case of atypical genitalia’ |
| 14:00 – 14:05 Introduction and poll – Christa Flück, Bern, Switzerland 14:05 – 14:25 For – Vickie Pasterski, Cambridge, UK 14:25 – 14:45 Against – David Sandberg, Ann Arbor, USA 14:45 – 15:15 Discussion & poll Coffee and Posters 15:15 – (Ground floor) |
| 15:30 – 17:30 Guided poster rounds |
| 19:30 – Social Evening |
| Symposium Day 3 (Saturday July 16th 2022) |
|---|
| Session 7 – Endocrine aspects at transition & beyond (09:00 – 10:45) Chair: Carla Bizzari, Rome, Italy |
| 09:00 – 09:25 Importance of transition for long term care – Philippe Touraine, Paris, France 09:25 – 09:50 Management of hypogonadotropic hypogonadism – Julia Rohayem, Munster, Germany 09:50 – 10:15 Assisted conception in Klinefelters – Claus Gravholt, Aarhus, Denmark 10:15 – 10:40 Long-term psychosocial outcome – Baudewijntje Kreukels, Amsterdam, The Netherlands 10:40 – 10.50 Discussion Coffee Break 10:50 – 11:15 |
| Session 8 – Future Directions (11:15 – 13:15) Chair: Hedi Claahsen, Nijmegen, Netherlands |
| 11:15 – 11:40 Advancing DSD/Intersex healthcare through inclusive and affirmative medical training programme – Ina Amarillo, Hershey, USA 11:40 – 12:05 The role of patient organisations in influencing care and research – Johan de Graaf, The Netherlands 12:05 – 12:30 Incorporating the ethical dimension into clinical practice – Jürg Streuli, Zurich, Switzerland 12:30 – 12:55 Benchmarking of care in DSD & CAH – Justin Davies, Southampton, UK 12:55 – 13:15 Discussion |
| 13:15 – Close (Faisal Ahmed) |
The 9th International Symposium on DSD and PG course, Bern, Switzerland, 14/07/2022-16/07/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 11 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity
I-DSD 